Abstract
The aim of the study was to evaluate TNF and TNF receptor levels in peripheral blood (PB) and bone marrow (BM) in correlation with clinical and laboratory parameters of B-CLL patients. TNF concentration was significantly higher in BM than in PB. In B-CLL patients elevated TNF and sTNF-RII plasma levels had a high correlation with adverse prognostic factors such as ZAP-70 and CD38. Moreover, the percentage of TNF-producing T cells was significantly higher in ZAP-70-positive comparing to ZAP-70-negative patients. TNF and sTNF-RII plasma levels were higher in the group of patients requiring treatment comparing to the patients who did not.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ADP-ribosyl Cyclase 1 / metabolism*
-
Adult
-
Aged
-
Aged, 80 and over
-
Biomarkers, Tumor / analysis
-
Bone Marrow Cells / metabolism*
-
Enzyme-Linked Immunosorbent Assay
-
Female
-
Flow Cytometry
-
Humans
-
Kaplan-Meier Estimate
-
Leukemia, Lymphocytic, Chronic, B-Cell / metabolism*
-
Leukemia, Lymphocytic, Chronic, B-Cell / mortality
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
-
Male
-
Middle Aged
-
Predictive Value of Tests
-
Prognosis
-
Receptors, Tumor Necrosis Factor / analysis
-
Receptors, Tumor Necrosis Factor / metabolism*
-
Tumor Necrosis Factor-alpha / analysis
-
Tumor Necrosis Factor-alpha / metabolism*
-
ZAP-70 Protein-Tyrosine Kinase / metabolism*
Substances
-
Biomarkers, Tumor
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
ZAP-70 Protein-Tyrosine Kinase
-
ADP-ribosyl Cyclase 1